- Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/ refractory multiple myeloma
-
Cho HJ, Jo JC, Lee YJ, Lee MW, Kim DY, Shin HJ, Im SN, Lee JH, Bae SH, Do YR, Lee WS, Kim MK, Jung J, Lee JM, Kim JH, Baek DW, Sohn SK, Moon JH
- KMID: 2544206
- Korean J Intern Med.
- 2023 Jul;38(4):578-578.
- doi: 10.3904/kjim.2022.183e
-
- CITED
-
- Close
- SHARE
-
- Close
- Treatment outcomes of IMEP as a front-line chemotherapy for patients with peripheral T-cell lymphomas
-
Lee JY, Lee SM, Choi MY, Kim KH, Joo YD, Im SN, Lee WS
- KMID: 2353500
- Blood Res.
- 2016 Sep;51(3):187-192.
- doi: 10.5045/br.2016.51.3.187
BACKGROUND: This study aimed to assess the treatment outcomes of ifosphamide, mesna, etoposide, and prednisolone (IMEP) combination regimen as a front-line chemotherapy in patients with peripheral T-cell lymphomas (PTCLs). METHODS: Clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/ refractory multiple myeloma
-
Cho HJ, Jo JC, Lee YJ, Lee MW, Kim DY, Shin HJ, Im SN, Lee JH, Bae SH, Do YR, Lee WS, Kim MK, Jung J, Lee JM, Kim JH, Baek DW, Sohn SK, Moon JH
- KMID: 2539976
- Korean J Intern Med.
- 2023 Mar;38(2):238-247.
- doi: 10.3904/kjim.2022.183
Background/Aims: Daratumumab has shown an encouraging antitumor effect in patients with multiple myeloma (MM), and was known to alter the immune properties by off-targeting immunosuppressive cells. Here, we aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
